Role of the peroxynitrite - Poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury

Current Pharmaceutical Design

Volumn 12, Issue 23, 2006, Pages 2903-2910

  Gero, Domokos ^a   Szabó, Csaba ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Hepatic; Liver; Nitric oxide; Peroxynitrite; Reperfusion; Sepsis; Superoxide

Indexed keywords

ADENOSINE TRIPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE; PEROXYNITRITE; SINGLE STRANDED DNA; SUPEROXIDE;

CELL DEATH; CELL FUNCTION; CHEMICAL REACTION; DNA STRAND BREAKAGE; ELECTRON TRANSPORT; ENZYME ACTIVATION; GLYCOLYSIS; HUMAN; LIVER INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SHOCK;

ANIMALS; HUMANS; LIVER; LIVER DISEASES; PEROXYNITROUS ACID; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 33746877849     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206777947579     Document Type: Review

References (70)

1. Ueda K, Hayaishi O. ADP-ribosylation. Annu Rev Biochem 1985; 54: 73-100.
2. Lautier D, Lagueux J, Thibodeau J, Menard L, Poirier GG. Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 1993; 122: 171-93.
3. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005; 4: 421-40.
4. Berger NA. Oxidant-induced cytotoxicity: a challenge for metabolic modulation. Am J Respir Cell Mol Biol 1991; 4: 1-3.
5. Junod AF, Jornot L, Petersen H. Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and fibroblasts. J Cell Physiol 1989; 140: 177-85.
6. Yamamoto K, Tsukidate K, Farber JL. Differing effects of the inhibition of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. Biochem Pharmacol 1993; 46: 483-91.
7. Kirkland JB. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase. Biochim Biophys Acta 1991; 1092: 319-25.
8. Spragg RG. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. Am J Respir Cell Mol Biol 1991; 4: 4-10.
9. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996; 93: 1753-8.
10. Szabo C, Zingarelli B, Salzman AL. Role of poly-ADP ribosyl-transferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 1996; 78: 1051-63.
11. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-35.
12. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
13. Thies RL, Autor AP. Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch Biochem Biophys 1991; 286: 353-63.
14. Szabo C, Saunders C, O'Connor M, Salzman AL. Peroxynitrite causes energy depletion and increases permeability via activation of poly (ADP-ribose) synthetase in pulmonary epithelial cells. Am J Respir Cell Mol Biol 1997; 16: 105-9.
15. Szabó C WH, Bauer PI, Kirsten E, O'Connor M, Zingarelli B, Mendeleyev J, Hasko G, Vizi ES, Salzmann AL, Kun E. Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly (ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways. Int J Oncol 1997; 10: 1093-101.
16. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
17. Southan GJ, Szabo C. Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 2003; 10: 321-40.
18. Skaper SD. Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury. Curr Drug Targets CNS Neurol Disord 2003; 2: 279-91.
19. Szabo G, Liaudet L, Hagl S, Szabo C. Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 2004; 61: 471-80.
20. Beneke S, Diefenbach J, Burkle A. Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions. Int J Cancer 2004; 111: 813-8.
21. Liu P, Yin K, Yue G, Wong PY. Role of nitric oxide in hepatic ischemia-reperfusion with endotoxemia. J Inflamm 1995; 46: 144-54.
22. Liu P, Yin K, Nagele R, Wong PY. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 1998; 284: 1139-46.
23. Sepodes B, Maio R, Pinto R, Marques C, Mendes-do-Vale J, McDonald MC, et al. Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc 2004; 36: 849-53.
24. Lehnert M, Arteel GE, Smutney OM, Conzelmann LO, Zhong Z, Thurman RG, et al. Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 2003; 19: 345-51.
25. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-26.
26. Szabo C, Billiar TR. Novel roles of nitric oxide in hemorrhagic shock. Shock 1999; 12: 1-9.
27. Wang Y, Mathews WR, Guido DM, Farhood A, Jaeschke H. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995; 4: 282-8.
28. Hines IN, Kawachi S, Harada H, Pavlick KP, Hoffman JM, Bharwani S, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002; 234-235: 229-37.
29. Kawachi S, Hines IN, Laroux FS, Hoffman J, Bharwani S, Gray L, et al. Nitric oxide synthase and postischemic liver injury. Biochem Biophys Res Commun 2000; 276: 851-4.
30. Bowes J, Thiemermann C. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the liver injury caused by ischaemia-reperfusion: a comparison with radical scavengers. Br J Pharmacol 1998; 124: 1254-60.
31. Mota-Filipe H, Sepodes B, McDonald MC, Cuzzocrea S, Pinto R, Thiemermann C. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 2002; 8: BR444-53.
32. Chen CF, Wang D, Hwang CP, Liu HW, Wei J, Lee RP, et al. The protective effect of niacinamide on ischemia-reperfusion-induced liver injury. J Biomed Sci 2001; 8: 446-52.
33. Szabo C. Nicotinamide: a jack of all trades (but master of none?). Intensive Care Med 2003; 29: 863-6.
34. Khandoga A, Biberthaler P, Enders G, Krombach F. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion. Crit Care Med 2004; 32: 472-7.
35. Khandoga A, Enders G, Biberthaler P, Krombach F. Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G553-60.
36. Zingarelli B, Salzman AL, Szabo C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998; 83: 85-94.
37. Deitch EA, Bridges W, Berg R, Specian RD, Granger DN. Hemorrhagic shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J Trauma 1990; 30: 942-5 1; discussion 951-2.
38. French JF, Thomas CE, Downs TR, Ohlweiler DF, Carr AA, Dage RC. Protective effects of a cyclic nitrone antioxidant in animal models of endotoxic shock and chronic bacteremia. Circ Shock 1994; 43: 130-6.
39. Szabo C, Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 1994; 2: 145-55.
40. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3(1): 2-32.
41. Szabo C, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 1995; 363: 235-8.
42. Szabo C, Salzman AL, Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 1995; 372: 229-32.
43. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, et al. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol 1994; 56: 759-68.
44. Wray GM, Hinds CJ, Thiemermann C. Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin. Shock 1998; 10: 13-9.
45. Kuhnle S, Nicotera P, Wendel A, Leist M. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun 1999; 263: 433-8.
46. Soriano FG, Liaudet L, Szabo E, Virag L, Mabley JG, Pacher P, et al. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002; 17: 286-92.
47. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, et al. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 2002; 30: 1071-82.
48. Corral J, Yelamos J, Hernandez-Espinosa D, Monreal Y, Mota R, Arcas I, et al. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol 2005; 166: 1089-98.
49. Veres B, Gallyas F, Jr., Varbiro G, Berente Z, Osz E, Szekeres G, et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003; 65: 1373-82.
50. Veres B, Radnai B, Gallyas F, Jr., Varbiro G, Berente Z, Osz E, et al. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 2004; 310: 247-55.
51. Szabo A, Hake P, Salzman AL, Szabo C. 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 1998; 10: 347-53.
52. McDonald MC, Filipe HM, Thiemermann C. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 1999; 128: 1339-45.
53. McDonald MC, Mota-Filipe H, Wright JA, Abdelrahman M, Threadgill MD, Thompson AS, et al. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 2000; 130: 843-50.
54. Watts JA, Grattan RM, 2nd, Whitlow BS, Kline JA. Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol Gastrointest Liver Physiol 2001; 281: G498-506.
55. Mongan PD, Karaian J, Van Der Schuur BM, Via DK, Sharma P. Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J Surg Res 2003; 112: 180-8.
56. Cuzzocrea S, Zingarelli B, Costantino G, Sottile A, Teti D, Caputi AP. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. Crit Care Med 1999; 27: 1517-23.
57. Cuzzocrea S, McDonald MC, Mazzon E, Filipe HM, Centorrino T, Lepore V, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med 2001; 29: 102-11.
58. Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS, et al. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. Intensive Care Med 2003; 29: 2016-25.
59. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C. Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 1998; 342: 67-76.
60. Cuzzocrea S, Caputi AP, Zingarelli B. Peroxynitrite-mediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy. Immunology 1998; 93: 96-101.
61. Kroger II, Ehrlich W, Klewer M, Gratz R, Dietrich A, Miesel R. The influence of antagonists of poly(ADP-ribose) metabolism on acetaminophen hepatotoxicity. Gen Pharmacol 1996; 27: 167-70.
62. Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, et al. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci 2005; 84: 201-8.
63. James LP, McCullough SS, Knight TR, Jaeschke H, Hinson JA. Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress. Free Radic Res 2003; 37: 1289-97.
64. Bajt ML, Knight TR, Farhood A, Jaeschke H. Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther 2003; 307: 67-73.
65. Fickert PTM, Fuchsbichler A, Zollner G, Wagner M, Zatloukal K, Wagner E, et al. Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cbolestatic liver injury. Hepatology 2003; 38(Suppl 1): 576A.
66. Scarabelli L, Merlo M, Bottazzi C, Demori I, Cesarone CF. Poly(ADP-ribose) polymerase activity in regenerating liver of hypothyroid rats. Boll Soc Ital Biol Sper 1998; 74: 29-34.
67. Shiobara M, Miyazaki M, Ito H, Togawa A, Nakajima N, Nomura F, et al. Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2001; 16: 338-44.
68. Bolanos JP, Garcia-Nogales P, Almeida A. Provoking neuroprotection by peroxynitrite. Curr Pharm Des 2004; 10(8): 867-77.
69. Domenico R. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies. Curr Pharm Des 2004; 10(14): 1667-76.
70. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005; 11(24):3141-58.